The Swiss pharma said it is to begin a phase IIb trial of one of its Farnesoid X receptor (FXR) agonists in combination with Allergan’s cenicriviroc in NASH. A group of around half a dozen ...
LJN452 is Novartis’ most advanced of two Farnesoid X receptor (FXR) agonists. Other companies such as Intercept, Allergan and Gilead have FXR agonists in their pipelines, but Hughes states that ...
Vice President Kamala Harris’ first video to her supporters after the election stunned social media users Tuesday. The video, shared by the Democratic Party’s official X account, featured ...
Iga Swiatek has been suspended for one month due to a doping violation, the International Tennis Integrity Agency announced today. Swiatek initially tested posted for the banned substance ...